Clinical trial
The Preemptive Analgesic Efficacy of Nefopam
NCT02561468 is registered in ClinicalTrials.gov with Seoul National University Bundang Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Preemptive Analgesic Efficacy of Nefopam
- Lead sponsor
- Seoul National University Bundang Hospital
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- April 30, 2015
- Completion date
- January 31, 2016
- Enrollment
- 94 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
breast neoplasm